https://openbell.ai/ 2026-09-18T07:29:37.678Z hourly 1.0 https://openbell.ai/support 2026-09-18T07:29:37.678Z monthly 0.7 https://openbell.ai/privacy 2026-09-18T07:29:37.678Z monthly 0.5 https://openbell.ai/terms 2026-09-18T07:29:37.678Z monthly 0.5 https://openbell.ai/feed.json 2026-09-18T07:29:37.678Z hourly 0.8 https://openbell.ai/news/LEDR:1789715484660 2026-09-18T07:11:24.660Z daily 0.9 https://cdn.brandfetch.io/LEDR/w/400/h/400?c=1idopYfmtR7ZKg8QMud Reported Earlier, Leader's Advantage Acquisition Prices $150M Initial Public Offering Of 15M Units At $10.00 Per Unit openbell Financial News https://openbell.ai/news/TTE:1789714804675 2026-09-18T07:00:04.675Z daily 0.9 https://cdn.brandfetch.io/TTE/w/400/h/400?c=1idopYfmtR7ZKg8QMud TotalEnergies, Global Infrastructure Partners Partner On African Oil & Gas Infrastructure In $1.8B Capital Contribution Deal openbell Financial News https://openbell.ai/news/HOOD:1789714796925 2026-09-18T06:59:56.925Z daily 0.9 https://cdn.benzinga.com/files/images/story/2026/09/18/Robinhood-Logo-Displayed-On-A-Smartphone.jpg?width=250&height=187 SEC Gives Tokenized Stocks a Five-Year Onchain Runway, Robinhood CEO Vlad Tenev Says ‘It’s a Good Day for US Innovation’ The SEC has established a five-year regulatory pathway for trading certain tokenized U.S. stocks on blockchain platforms, allowing conditional exemptions from exchange and dealer-registration rules. This 'Innovation Exemption' enables tokenized National Market System stocks to trade while the SEC develops permanent regulations. Robinhood CEO Vlad Tenev praised the decision, highlighting benefits such as instant settlement and 24/7 trading. The SEC's move is seen as a step towards enhancing liquidity and reducing costs in the trading of tokenized assets. https://openbell.ai/news/AMD:1789713950572 2026-09-18T06:45:50.572Z daily 0.9 https://cdn.benzinga.com/files/images/story/2026/09/18/Market-sentiment---Fear-and-Greed.jpg?width=250&height=187 Nasdaq Jumps Over 400 Points as Crude Oil Falls: Investor Sentiment Improves, Greed Index Remains in ‘Fear’ Zone On Thursday, the Nasdaq Composite rose over 400 points, closing at 26,418.30, driven by a decline in Treasury yields and crude oil prices. The Federal Reserve raised the federal funds target range by 25 basis points to 3.75%-4.00%, marking its first rate increase since 2023. Initial jobless claims fell to 196,000, below the consensus of 206,500, while the Philadelphia Fed manufacturing index slowed but exceeded estimates. The Technology Select Sector SPDR Fund led gains, with Intel Corp. and Advanced Micro Devices Inc. surging approximately 8% and over 6%, respectively. https://openbell.ai/news/EWU:1789713553840 2026-09-18T06:39:13.840Z daily 0.9 https://cdn.brandfetch.io/EWU/w/400/h/400?c=1idopYfmtR7ZKg8QMud U.K. Core Retail Sales (MoM) For August 0.6% Vs. -0.2% Est.; -0.9% Prior openbell Financial News https://openbell.ai/news/TCRT:1789713036849 2026-09-18T06:30:36.849Z daily 0.9 https://cdn.benzinga.com/files/images/story/2026/09/18/Stock-Trading-Analysis-Concept-With-Inve.jpg?width=250&height=187 Alaunos Therapeutics (TCRT) Stock Soars Over 29% After-Hours: Here's What's Going On Alaunos Therapeutics Inc. (NASDAQ: TCRT) saw its stock price rise by 29.28% to $2.07 after-hours following the approval of its Second Amended and Restated By-Laws, which lowers the quorum required for shareholder votes from a majority to one-third of outstanding voting shares. This change, effective immediately, is expected to facilitate future corporate actions such as financings and mergers. The company's market capitalization is approximately $4.06 million, and its stock has experienced a 36% decline over the past year. https://openbell.ai/news/NUE:1789712298869 2026-09-18T06:18:18.869Z daily 0.9 https://cdn.benzinga.com/files/images/story/2026/09/18/Stuttgart--Germany---05-20-2022-Person-H.jpg?width=250&height=187 Nucor, BlackBerry and 3 Stocks to Watch Heading Into Friday Nucor Corp. (NYSE:NUE) expects third-quarter earnings of $5.55 to $5.65 per diluted share, significantly up from $2.63 per share in the same quarter last year, although its shares fell 3.1% to $257.00 in after-hours trading. BlackBerry Ltd. (NYSE:BB) shares increased by 1.9% to $8.09 after announcing a partnership between its QNX division and Sift. Clean Harbors Inc. (NYSE:CLH) priced a $600 million private offering of senior notes due 2034, with shares closing down 1.1% at $315.55. McDonald's Corp. (NYSE:MCD) raised its quarterly dividend from $1.86 to $1.93 per share, resulting in a 0.3% increase in shares to $249.19. https://openbell.ai/news/XENE:1789711483287 2026-09-18T06:04:43.287Z daily 0.9 https://cdn.benzinga.com/files/images/story/2026/09/18/Guidance-Would-Become-Regulation.jpg?width=250&height=187 Xenon Pharmaceuticals (XENE) Shares Fall 25% After Hours: Here's Why Xenon Pharmaceuticals Inc. (NASDAQ: XENE) shares fell 25.39% to $42.79 in after-hours trading following a temporary pause in enrollment for new patients in its psychiatry studies due to neuropsychiatric adverse events. The company, which focuses on therapies for epilepsy and mood disorders, stated that current participants will continue in the trials and that the pause is expected to be temporary. Xenon has a market capitalization of approximately $5.55 billion and has seen its stock rise 51.88% over the past year. https://openbell.ai/news/TJX:1789710249174 2026-09-18T05:44:09.174Z daily 0.9 https://cdn.benzinga.com/files/images/story/2026/09/18/The-Sign-Outside-The-Tjx-Corporate-Headq.jpg?width=250&height=187 TJX Companies (TJX) Stock Is Trending After-Hours: Here's Why TJX Companies, Inc. (NYSE: TJX) shares rose 0.51% to $127.20 in after-hours trading following a 3.02% increase to $126.55 during the regular session. The company appointed Craig A. Pintoff to its Board of Directors, effective Wednesday, who previously served at United Rentals, Inc. TJX also declared a quarterly dividend of $0.48 per share, payable on December 3, to shareholders of record as of November 12. The company's market capitalization stands at $139.20 billion, with a 52-week trading range between $122.78 and $170. https://openbell.ai/news/RARE:1789705600607 2026-09-18T04:26:40.607Z daily 0.9 https://cdn.benzinga.com/files/images/story/2026/09/18/Ultragenyx-Sign-And-Logo-Atop-American-B.jpg?width=250&height=187 Ultragenyx Pharmaceutical (RARE) Stock Jumps After Hours: Here's Why It Is Trending Ultragenyx Pharmaceutical Inc. (NASDAQ: RARE) saw its stock rise 2.55% to $14.87 in after-hours trading following the FDA's full approval of FAYUVI, the first treatment for Sanfilippo syndrome Type A. The approval is based on nearly eight years of clinical data showing significant cognitive improvements in treated patients. Ultragenyx has a market capitalization of $1.43 billion, with a 52-week high of $39.89 and a low of $12.73, although the stock has fallen 50.19% over the past year. https://openbell.ai/news/BTCUSD:1789703825505 2026-09-18T03:57:05.505Z daily 0.9 https://cdn.benzinga.com/files/images/story/2026/09/18/January-16--2025---Washington-Dc-The-Sen.jpg?width=250&height=187 Scott Bessent Says Financing Iran With Crypto 'Not Beyond' Treasury's Reach, Sanctions Bitcoin Exchange Tied to Iranian Financier Babak Zanjani Treasury Secretary Scott Bessent announced new sanctions against BitBank, a Bitcoin exchange linked to Iranian financier Babak Zanjani, emphasizing that efforts to finance the Iranian regime through cryptocurrencies are within the Treasury's oversight. The sanctions also target Zanjani's associates and are part of 'Operation Economic Outcast,' aimed at isolating Iran economically. Zanjani reportedly used BitBank to transfer hundreds of millions of dollars in Bitcoin to the Islamic Revolutionary Guard Corps between June and July. https://openbell.ai/news/BB:1789703468039 2026-09-18T03:51:08.039Z daily 0.9 https://cdn.benzinga.com/files/images/story/2026/09/18/BlackBerry-Ltd.jpg?width=250&height=187 Why Is BlackBerry (BB) Stock Trending After Hours BlackBerry Ltd. (NYSE: BB) shares rose 1.89% to $8.09 after hours following a partnership announcement between Sift and BlackBerry's QNX division, which enhances real-time visibility into embedded systems. During regular trading, shares increased by 3.93% to close at $7.94. BlackBerry's QNX segment reported a 26% year-over-year revenue increase to $72.3 million in the last quarter. The company is set to announce its second-quarter fiscal 2027 earnings on September 24. https://openbell.ai/news/ES:1789691485033 2026-09-18T00:31:25.033Z daily 0.9 https://cdn.brandfetch.io/ES/w/400/h/400?c=1idopYfmtR7ZKg8QMud Social Media Discussion: $ES A former software engineer shares insights on their futures trading system, detailing its conditions for execution and acknowledging some overfitting in their backtest. The community response is generally positive, with others confirming the potential edge of the strategy. Meanwhile, a daily discussion thread on r/stocks reflects ongoing trading sentiment and key market themes. https://openbell.ai/news/EPOW:1789689000666 2026-09-17T23:50:00.666Z daily 0.9 https://cdn.brandfetch.io/EPOW/w/400/h/400?c=1idopYfmtR7ZKg8QMud Trading Halt: Halted at 7:50:00 p.m. ET - Trading Halt: Halt News Pending openbell Financial News https://openbell.ai/news/RARE:1789682393240 2026-09-17T21:59:53.240Z daily 0.9 https://cdn.brandfetch.io/RARE/w/400/h/400?c=1idopYfmtR7ZKg8QMud Ultragenyx Pharmaceutical Exec Says U.S. Per Patient Wholesale Acquisition Cost For Fayuvi Is Set At $3.95M Ultragenyx Pharmaceutical has announced that the U.S. wholesale acquisition cost for its drug Fayuvi is set at $3.95 million per patient. This pricing decision is part of the company's strategy to position Fayuvi in the market. The stock ticker for Ultragenyx is RARE. https://openbell.ai/news/FEAM:1789682168197 2026-09-17T21:56:08.197Z daily 0.9 https://cdn.brandfetch.io/FEAM/w/400/h/400?c=1idopYfmtR7ZKg8QMud 5E Advanced Materials Q4 EPS $(0.14) Beats $(0.32) Estimate 5E Advanced Materials (NASDAQ: FEAM) reported a Q4 loss of $(0.14) per share, surpassing the analyst estimate of $(0.32) by 56.25%. This represents a 72.55% improvement compared to losses of $(0.51) per share in the same quarter last year. https://openbell.ai/news/SLP:1789681834327 2026-09-17T21:50:34.327Z daily 0.9 https://cdn.brandfetch.io/SLP/w/400/h/400?c=1idopYfmtR7ZKg8QMud Simulations Plus Announces The FDA Cosmetics Regulatory Science Branch Has Licensed ADMET Predictor To Support Its Computational Research For Modern Cosmetic Safety Assessment Simulations Plus, Inc. (NASDAQ: SLP) announced that the FDA's Cosmetics Regulatory Science Branch has licensed its ADMET Predictor platform to enhance computational research for modern cosmetic safety assessment. This licensing agreement signifies an expansion of Simulations Plus technology within the FDA, emphasizing the importance of predictive modeling in regulatory research. The ADMET Predictor utilizes advanced AI and machine learning to assess exposure and toxicity, supporting the FDA's research into New Approach Methodologies. Additionally, the company is collaborating with the International Collaboration on Cosmetics Safety to promote animal-free safety assessments. https://openbell.ai/news/MEDS:1789680458823 2026-09-17T21:27:38.823Z daily 0.9 https://cdn.brandfetch.io/MEDS/w/400/h/400?c=1idopYfmtR7ZKg8QMud DataMEDS AI Enters Settlement Agreement On Sept 11, 2026; Expects To Extinguish $19M In Liability From Agreement On September 11, 2026, DataMEDS AI, Inc. entered into a settlement agreement that will allow the company to extinguish approximately $19 million in liability. The company paid $450,000 as part of the agreement, which included $350,000 for the repurchase of 364,099 shares of common stock and $100,000 for settling claims related to a prior Membership Interest Purchase Agreement. The settlement resolves ongoing litigation involving several parties, including Brian Norton and RxERP, Inc. https://openbell.ai/news/TMCI:1789679853503 2026-09-17T21:17:33.503Z daily 0.9 https://cdn.brandfetch.io/TMCI/w/400/h/400?c=1idopYfmtR7ZKg8QMud Treace Medical Presents 5-Year ALIGN3D Data Showing 0.8% Recurrence Rate Alongside MTA3D And SPRINT Clinical Results At AOFAS 2026 Treace Medical Concepts, Inc. (NASDAQ: TMCI) presented results from three clinical studies at the AOFAS Annual Meeting, including the 5-year ALIGN3D data showing a 0.8% recurrence rate for their Lapiplasty procedure. The presentations also covered findings from the MTA3D Adductoplasty and SPRINT SpeedPlate studies, highlighting the company's advancements in surgical treatments for bunions and foot & ankle conditions. https://openbell.ai/news/WBD:1789679791399 2026-09-17T21:16:31.399Z daily 0.9 https://cdn.brandfetch.io/WBD/w/400/h/400?c=1idopYfmtR7ZKg8QMud Federal Communications Commission Approves Foreign Funding For Paramount Warner Brothers Merger Deal The Federal Communications Commission (FCC) has approved foreign funding for the merger deal between Paramount Global and Warner Bros. Discovery (stock ticker: WBD). This approval is a significant step in facilitating the merger, which is expected to enhance the companies' competitive positioning in the media industry. The decision allows for the necessary financial backing to proceed with the consolidation. https://openbell.ai/news/MCD:1789679523580 2026-09-17T21:12:03.580Z daily 0.9 https://cdn.brandfetch.io/MCD/w/400/h/400?c=1idopYfmtR7ZKg8QMud McDonald's Increases Quarterly Dividend From $1.86 To $1.93 Per Share McDonald's Board of Directors has declared a quarterly cash dividend of $1.93 per share, marking a 4% increase from the previous dividend of $1.86. This increase signifies the company's 50th consecutive year of dividend growth, reinforcing its status as a 'Dividend King.' The new dividend will be payable on December 15, 2026, to shareholders of record as of December 1, 2026. Further details on McDonald's growth strategy will be shared at the upcoming Investor Day on September 23, 2026. https://openbell.ai/news/AAUC:1789679456196 2026-09-17T21:10:56.196Z daily 0.9 https://cdn.brandfetch.io/AAUC/w/400/h/400?c=1idopYfmtR7ZKg8QMud Allied Gold Connects Kurmuk Mine To Ethiopian Grid And Crushes First Ore Ahead Of Commercial Production Allied Gold Corporation has successfully connected its Kurmuk Mine in Ethiopia to the national electrical grid, marking a significant milestone in its operational readiness. The company has also crushed its first ore, with mining activities progressing well and ore stockpiles being built to support the ramp-up to commercial production. The 88-kilometre power line provides electricity at a fixed rate of approximately US$0.04 per kilowatt-hour under a 20-year agreement, which is expected to contribute to low production costs. https://openbell.ai/news/OCCI:1789679285655 2026-09-17T21:08:05.655Z daily 0.9 https://cdn.brandfetch.io/OCCI/w/400/h/400?c=1idopYfmtR7ZKg8QMud OFS Credit Co Q3 Adj. EPS $0.21 Misses $0.23 Estimate, Sales $8.646M Miss $9.417M Estimate OFS Credit Co (NASDAQ: OCCI) reported Q3 adjusted earnings per share of $0.21, missing the analyst estimate of $0.23 by 8.7%. This represents a 32.26% decrease from $0.31 per share in the same quarter last year. The company's sales totaled $8.646 million, falling short of the $9.417 million estimate by 8.19%, and reflecting a 27.19% decline from $11.875 million in the prior year. https://openbell.ai/news/KXIN:1789679166539 2026-09-17T21:06:06.539Z daily 0.9 https://cdn.benzinga.com/files/images/story/2025/11/06/movers_2.jpg?width=250&height=187 12 Consumer Discretionary Stocks Moving In Thursday's After-Market Session In Thursday's after-market session, Kaixin Holdings (NASDAQ: KXIN) shares rose by 10.9% to $1.94, with a market cap of $1.8 million. Other notable gainers included Sports Entertainment (NASDAQ: SEGG), which increased by 8.95% to $3.31, and Uxin (NASDAQ: UXIN), up 8.09% to $1.17, with a market cap of $226.4 million. Conversely, Ping An Biomedical (NASDAQ: PASW) saw a decline of 8.6% to $0.12, while Vera Bradley (NASDAQ: VRA) fell by 5.42% to $4.02. https://openbell.ai/news/TCRT:1789679166292 2026-09-17T21:06:06.292Z daily 0.9 https://cdn.benzinga.com/files/images/story/2025/11/06/movers_3.jpg?width=250&height=187 12 Health Care Stocks Moving In Thursday's After-Market Session In Thursday's after-market session, Alaunos Therapeutics (NASDAQ:TCRT) saw its shares rise by 30.0% to $2.08, with a market cap of $3.2 million. Other notable gainers included cbdMD (AMEX:YCBD) up 13.84% to $0.57, and Telomir Pharmaceuticals (NASDAQ:TELO) which increased by 11.6% to $1.25. Conversely, Xenon Pharmaceuticals (NASDAQ:XENE) experienced a significant decline of 23.7%, falling to $43.75, while Myriad Genetics (NASDAQ:MYGN) dropped 9.32% to $3.75. https://openbell.ai/news/VRME:1789679166079 2026-09-17T21:06:06.079Z daily 0.9 https://cdn.benzinga.com/files/images/story/2025/11/06/movers_1.jpg?width=250&height=187 12 Industrials Stocks Moving In Thursday's After-Market Session In Thursday's after-market session, VerifyMe (NASDAQ: VRME) saw a significant stock increase of 27.3%, reaching $0.98, with a market cap of $8.8 million. Other notable gainers included Professional Diversity (NASDAQ: IPDN), which rose 14.11% to $3.93, and Turbo Energy (NASDAQ: TURB), up 8.95% to $1.46. Conversely, AIAI Holdings (NASDAQ: AIAI) experienced the largest decline, falling 7.6% to $3.03, while Toppoint Holdings (AMEX: TOPP) dropped 6.85% to $0.15. https://openbell.ai/news/ABTS:1789679165780 2026-09-17T21:06:05.780Z daily 0.9 https://cdn.benzinga.com/files/images/story/2025/11/06/movers_4.jpg?width=250&height=187 12 Information Technology Stocks Moving In Thursday's After-Market Session During Thursday's after-market session, Abits Group (NASDAQ: ABTS) saw a significant stock increase of 22.8%, reaching $1.72, with a market value of $4.4 million. Other notable gainers included CID Holdco (NASDAQ: DAIC) up 10.94% to $5.88 and NOVONIX (NASDAQ: NVX) up 9.24% to $3.31. Conversely, Datasea Intelligent Tech (NASDAQ: DTSS) experienced the largest decline, falling 12.3% to $1.07, while AuthID (NASDAQ: AUID) dropped 5.63% to $0.46. https://openbell.ai/news/BTCUSD:1789678821005 2026-09-17T21:00:21.005Z daily 0.9 https://cdn.benzinga.com/files/images/story/2026/09/17/Golden-Bitcoin-Coin-Is-In-Red-And-Blue-S.jpg?width=250&height=187 Grayscale: Bitcoin Put in the Bottom at $58,000, 'Green Light' From Here Grayscale's Head of Research, Zach Pandl, stated that Bitcoin's June low of $58,000 is the cycle bottom, and the firm is now advising clients to allocate funds. As of Thursday, Bitcoin is trading above $76,000, reflecting a 1% increase over 24 hours but still 39% below its all-time high of approximately $126,000. Pandl's recommendation follows a thorough analysis of market conditions, and he remains confident despite recent market challenges, including the Senate's defeat of the Clarity Act and the Federal Reserve's rate hike. https://openbell.ai/news/QQQ:1789678264263 2026-09-17T20:51:04.263Z daily 0.9 https://cdn.benzinga.com/files/images/story/2026/09/17/Qqq-Word-On-Yellow-Sticky-With-Calculato.jpg?width=250&height=187 Ten-Year Treasury Yield Hits 5%: Why QQQ Could Face More Pressure Than Value ETFs The 10-year Treasury yield has recently approached 5%, impacting growth-heavy ETFs like the Invesco QQQ Trust (NASDAQ: QQQ). Historical data indicates that when the yield is at this level, the S&P 500 typically sees lower average returns, raising concerns about the valuation of growth stocks compared to value-focused funds. In contrast, the Vanguard Value ETF (NYSE: VTV) has shown resilience, gaining 1.5% over the past three months while QQQ has declined by 2.5%. The current yield environment suggests a need for valuation discipline among growth ETFs. https://openbell.ai/news/UPXI:1789678255293 2026-09-17T20:50:55.293Z daily 0.9 https://cdn.brandfetch.io/UPXI/w/400/h/400?c=1idopYfmtR7ZKg8QMud Upexi Q4 EPS $(0.21) Misses $(0.12) Estimate, Sales $3.149M Miss $7.572M Estimate Upexi (NASDAQ: UPXI) reported a Q4 loss of $(0.21) per share, missing the analyst estimate of $(0.12) by 75%. This loss represents a 16% improvement from $(0.25) per share in the same quarter last year. The company's sales for the quarter were $3.149 million, falling short of the $7.572 million estimate by 58.42% and marking a 4.17% decrease from $3.286 million in the previous year. https://openbell.ai/news/SPCX:1789678159192 2026-09-17T20:49:19.192Z daily 0.9 https://cdn.brandfetch.io/SPCX/w/400/h/400?c=1idopYfmtR7ZKg8QMud NASA Selects SpaceX To Launch StarBurst Mission In 2028 Under $1B, 10-Year VADR Contract NASA has selected SpaceX to launch its StarBurst mission, aimed at investigating neutron star mergers and gamma-ray bursts, under a firm-fixed-price task order as part of the $1 billion VADR contract. The mission will utilize a Falcon 9 rocket for a Bandwagon rideshare launch from Cape Canaveral, scheduled for no earlier than 2028. This contract allows NASA to procure launch services over a 10-year period, supporting lower-cost investigations in astrophysics. https://openbell.ai/news/PAAI:1789677515053 2026-09-17T20:38:35.053Z daily 0.9 https://cdn.benzinga.com/files/images/story/2026/09/17/Abstract-Images--Candlestick-Charts-For-.jpg?width=250&height=187 Why Paradium.AI Stock Skyrocketed Thursday: Inside the $1 Billion Deal and Complex Corporate Reunion Paradium.AI Inc (NYSE: PAAI) shares surged 270% to $3.33 following the announcement of a 10-year, $1 billion deal to migrate its media portfolio to RTB Digital Inc's platform. The agreement allows Roundtable, led by CEO James Heckman, to absorb nearly two dozen media brands from Paradium, including TheStreet and Men's Journal, while securing a 49% minority stake through an $89 million cash and stock transaction. This deal marks a significant corporate reunion for Heckman, who originally founded TheMaven, now Paradium.AI. https://openbell.ai/news/MOD:1789677387913 2026-09-17T20:36:27.913Z daily 0.9 https://cdn.brandfetch.io/MOD/w/400/h/400?c=1idopYfmtR7ZKg8QMud Modine Sets September 28, 2026 Record Date For Performance Technologies Spin-Off And Merger With Gentherm, Which Declares ~$1.90/Share Special Dividend Modine Manufacturing Company has set September 28, 2026, as the record date for the spin-off of its Performance Technologies business, which will be merged with Gentherm. Following the completion of this transaction, Gentherm will pay a special cash dividend of approximately $1.90 per share, totaling around $58.35 million, to its shareholders. The spin-off distribution is expected to occur on October 1, 2026, with the merger completing on the same day, pending the fulfillment of certain closing conditions. https://openbell.ai/news/STLD:1789677275709 2026-09-17T20:34:35.709Z daily 0.9 https://cdn.brandfetch.io/STLD/w/400/h/400?c=1idopYfmtR7ZKg8QMud Steel Dynamics Sees Q3 2026 EPS To $5.34-$5.38, Up From $3.69 In Q2 And $2.74 Year Ago openbell Financial News https://openbell.ai/news/OPFI:1789677223787 2026-09-17T20:33:43.787Z daily 0.9 https://cdn.brandfetch.io/OPFI/w/400/h/400?c=1idopYfmtR7ZKg8QMud BNCCORP Stockholders Approve OppFi Merger; BNCC Stockholders To Receive $19.375/Share And 1.9 Shares of OppFi ClassA Common Stock For Each BNCC Share openbell Financial News https://openbell.ai/news/NUE:1789677223099 2026-09-17T20:33:43.099Z daily 0.9 https://cdn.brandfetch.io/NUE/w/400/h/400?c=1idopYfmtR7ZKg8QMud Nucor Sees Q3 2026 EPS Of $5.55 to $5.65 Per Diluted Share, Up From $2.63 In Q3 2025 Nucor Corporation (NYSE: NUE) has projected its third quarter 2026 earnings per diluted share to be between $5.55 and $5.65, a significant increase from $2.63 in Q3 2025. The company reported second quarter 2026 net earnings of $5.04 per diluted share, which included a $61 million non-cash benefit from its investment in Helion. Nucor anticipates earnings growth in its steel mills and steel products segments, while expecting a decline in the raw materials segment. Additionally, the company has repurchased approximately 2.03 million shares at an average price of $247.04 per share, returning about $1.36 billion to shareholders year-to-date. https://openbell.ai/news/WHLR:1789677120652 2026-09-17T20:32:00.652Z daily 0.9 https://cdn.brandfetch.io/WHLR/w/400/h/400?c=1idopYfmtR7ZKg8QMud Wheeler Real Estate Investment Trust shares are trading lower after the company announced a 1-for-9 reverse stock split. openbell Financial News https://openbell.ai/news/HUBG:1789677065053 2026-09-17T20:31:05.053Z daily 0.9 https://cdn.brandfetch.io/HUBG/w/400/h/400?c=1idopYfmtR7ZKg8QMud Hub Group Says It Received Nasdaq Delisting Determination Over Delinquent 10-K And Two 10-Qs; Plans To Appeal By September 23 openbell Financial News https://openbell.ai/news/LOOP:1789677001072 2026-09-17T20:30:01.072Z daily 0.9 https://cdn.brandfetch.io/LOOP/w/400/h/400?c=1idopYfmtR7ZKg8QMud Trading Halt: Halt status updated at 4:30:00 PM ET: Quotation Resumption: News and Resumption Times openbell Financial News https://openbell.ai/news/PXED:1789676658424 2026-09-17T20:24:18.424Z daily 0.9 https://cdn.brandfetch.io/PXED/w/400/h/400?c=1idopYfmtR7ZKg8QMud Phoenix Education Enters Into Definitive Agreement To Acquire Fuel50 Phoenix Education Partners, Inc. (NYSE: PXED) has entered into a definitive agreement to acquire Fuel50, Inc., an AI-powered workforce transformation platform. The acquisition aims to enhance Fuel50's capabilities and expand its reach with enterprise employers, focusing on AI-powered workforce intelligence and talent mobility. Following the transaction, which is expected to close within 30 days, Fuel50 will operate under its own brand and be led by Co-founder Jo Mills as CEO. Macquarie Capital acted as the exclusive financial advisor for Fuel50 in this transaction. https://openbell.ai/news/PXED:1789676615107 2026-09-17T20:23:35.107Z daily 0.9 https://cdn.brandfetch.io/PXED/w/400/h/400?c=1idopYfmtR7ZKg8QMud Phoenix Education Partners Acquisition Price For Fuel50 Is $31.5M Cash; Fuel50 Securityholders May Receive Earnout Payments Up To $8.50M Through 2027; Acquisition To Be Funded With Cash On Hand; Fuel50 To Continue Operating Under Its Own Brand After Acquisition On September 16, 2026, Phoenix Education Partners, Inc. announced its agreement to acquire Fuel50 Inc. for approximately $31.5 million in cash, with potential earnout payments of up to $8.5 million through 2027 based on performance milestones. The acquisition will be funded using cash on hand and is expected to close within 30 days, pending customary closing conditions. Fuel50 will continue to operate under its own brand following the acquisition. https://openbell.ai/news/GPRO:1789676404305 2026-09-17T20:20:04.305Z daily 0.9 https://cdn.brandfetch.io/GPRO/w/400/h/400?c=1idopYfmtR7ZKg8QMud GoPro Says It Received Nasdaq Notice That It Regained Compliance With $1 Minimum Bid Price Requirement GoPro has announced that it has received a notice from Nasdaq confirming that it has regained compliance with the $1 minimum bid price requirement. This development indicates that the company's stock price has risen above the threshold necessary to meet Nasdaq's listing standards. The compliance is significant for maintaining its listing on the exchange. https://openbell.ai/news/XENE:1789676346036 2026-09-17T20:19:06.036Z daily 0.9 https://cdn.brandfetch.io/XENE/w/400/h/400?c=1idopYfmtR7ZKg8QMud Xenon Pharmaceuticals shares are trading lower after the company announced it voluntarily initiated a temporary pause of enrollment of new patients in ongoing psychiatry studies. openbell Financial News https://openbell.ai/news/BIIB:1789676269407 2026-09-17T20:17:49.407Z daily 0.9 https://cdn.brandfetch.io/BIIB/w/400/h/400?c=1idopYfmtR7ZKg8QMud Biogen Announces Publication Of Phase 3 VALIANT Adolescent Subgroup Data In CJASN Demonstrating 75% Proteinuria Reduction For EMPAVELI In Rare Kidney Diseases Biogen Inc. announced the publication of Phase 3 VALIANT study results showing that adolescents treated with EMPAVELI achieved a 75% relative reduction in proteinuria within 6 months compared to placebo. The study, which included nearly half of the adolescent cohort, demonstrated significant improvements in kidney function stabilization. This follows a recent FDA label expansion for EMPAVELI, making it the first approved treatment for adolescents aged 12 and older for both reducing proteinuria and loss of kidney function. https://openbell.ai/news/PXED:1789676260442 2026-09-17T20:17:40.442Z daily 0.9 https://cdn.brandfetch.io/PXED/w/400/h/400?c=1idopYfmtR7ZKg8QMud Phoenix Education Enters Into Definitive Agreement To Acquire Fuel50; Terms Undisclosed Phoenix Education Partners, Inc. (NYSE: PXED) has entered into a definitive agreement to acquire Fuel50, an AI-powered workforce transformation platform, with the terms undisclosed. The acquisition aims to enhance Fuel50's capabilities and expand its reach among enterprise employers, focusing on AI-powered workforce intelligence and talent mobility. Following the completion of the transaction, which is expected to close within 30 days, Fuel50 will continue to operate under its own brand, led by Co-founder Jo Mills as CEO. Macquarie Capital acted as the exclusive financial advisor for Fuel50 in this transaction. https://openbell.ai/news/XMAX:1789676253775 2026-09-17T20:17:33.775Z daily 0.9 https://cdn.brandfetch.io/XMAX/w/400/h/400?c=1idopYfmtR7ZKg8QMud XMax's XMax AI Announces Non-Binding Letter Of Cooperation With Korea's apM Group To Develop Fashion-Specific AI Models, Explore Joint Venture openbell Financial News https://openbell.ai/news/IPAR:1789676219498 2026-09-17T20:16:59.498Z daily 0.9 https://cdn.brandfetch.io/IPAR/w/400/h/400?c=1idopYfmtR7ZKg8QMud Interparfums Announces 20-Year Extension Of Exclusive Worldwide Roberto Cavalli And Just Cavalli Fragrance License With Marquee Brands Through December 31, 2046 openbell Financial News https://openbell.ai/news/PBYI:1789676126217 2026-09-17T20:15:26.217Z daily 0.9 https://cdn.brandfetch.io/PBYI/w/400/h/400?c=1idopYfmtR7ZKg8QMud Puma Biotechnology Initiates Phase 2 ALISCA-Lung2 Trial Of Alisertib In Advanced Small Cell Lung Cancer Puma Biotechnology, Inc. (NASDAQ: PBYI) has initiated the Phase II ALISCA-Lung2 trial (PUMA-ALI-4202) to evaluate alisertib in combination with paclitaxel for advanced small cell lung cancer. The trial aims to enroll approximately 50 patients who have progressed after platinum-based chemotherapy and immunotherapy. The primary endpoint focuses on the safety and tolerability of the treatment, while secondary endpoints include various measures of treatment efficacy and the evaluation of clinical biomarkers to identify patients who may benefit most. https://openbell.ai/news/PBYI:1789675801084 2026-09-17T20:10:01.084Z daily 0.9 https://cdn.brandfetch.io/PBYI/w/400/h/400?c=1idopYfmtR7ZKg8QMud Puma Biotechnology Initiates ALISertib In CAncer Phase II Trial Of Alisertib In Combination With Paclitaxel For Treatment Of Patients With Advanced Small Cell Lung Cancer Puma Biotechnology, Inc. (NASDAQ: PBYI) has initiated the ALISertib in CAncer (ALISCA®-Lung2) Phase II trial to evaluate alisertib in combination with paclitaxel for patients with advanced small cell lung cancer. The trial will enroll approximately 50 patients who have progressed after platinum-based chemotherapy and immunotherapy, focusing on the safety and tolerability of the treatment. Secondary endpoints will assess response rates, disease control, and survival metrics, while also evaluating clinical biomarkers for patient benefit. https://openbell.ai/news/FERA:1789675764699 2026-09-17T20:09:24.699Z daily 0.9 https://cdn.brandfetch.io/FERA/w/400/h/400?c=1idopYfmtR7ZKg8QMud UPDATE: Fifth Era Acquisition Corp. I Receives Nasdaq Non-Compliance Notice Over Minimum Shareholder Requirement On September 14, 2026, Fifth Era Acquisition Corp. I received a notice from Nasdaq indicating non-compliance with the Minimum Total Holders Requirement, which mandates at least 400 total holders for continued listing. The company has 45 days to submit a plan to regain compliance, with the possibility of a 180-day extension if accepted. If the plan is not accepted, the company can appeal the decision or consider transferring its securities to The Nasdaq Capital Market. This notification does not currently affect the trading of the company's securities.